Fig. 1.
Simplified schematic representation of the main pathophysiological mechanisms of thyroid injury due to COVID-19 infection. SARS-CoV-2 can damage the thyroid gland in a direct and indirect way. Direct toxicity ACE2 and TMPRSS2 on the surface of thyroid follicular cells serve as an entrance gate for the internalization of the virus into the host cells. The same possibly applies to the integrin αvβ3, leading to thyroid gland damage. Additionally, it is suggested that the virus can affect the hypothalamus and the pituitary resulting in HPA-axis dysfunction and, thus, thyroid abnormalities. Indirect toxicity: SARS-CoV-2-induced pulmonary and systemic inflammation and innate immune system activation could potentially damage the thyroid gland in an indirect way. Finally, corticosteroids, which are widely used in the management of COVID-19 patients, inhibit pituitary thyrotrope cells and TRH-release. ACE2 angiotensin-converting enzyme 2; COVID-19 Coronavirus disease 2019; HPA-Axis hypothalamic–pituitary–adrenal axis; SARS-CoV-2 severe acute respiratory syndrome coronavirus 2; TMPRSS2 transmembrane serine protease 2; TRH thyrotropin-releasing hormone